Works matching DE "DOCETAXEL"
Results: 3379
In Hormone-Naive Metastatic Prostate Cancer, Should All Patients Now Receive Docetaxel? No, Not Yet.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 10, p. 881
- By:
- Publication type:
- Article
In Hormone-Naive Metastatic Prostate Cancer, Should All Patients Now Receive Docetaxel? Yes; We Must Beware of Drawing Conclusions From a Subset Analysis.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 10, p. 880
- By:
- Publication type:
- Article
Value in Oncology.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 643
- Publication type:
- Article
Prostate Cancer: What Did We Learn From the 2012 Annual Scientific Meeting of ASCO?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 12, p. 1216
- By:
- Publication type:
- Article
Can We Abandon Anthracyclines for Early Breast Cancer Patients?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 115
- By:
- Publication type:
- Article
Neoadjuvant Capecitabine Added to Standard Treatment Helps to Eradicate Tumors in Patients With Early Breast Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 11, p. 968
- Publication type:
- Article
Bevacizumab in Breast Cancer: The Best Is Yet to Come?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 4, p. 332
- By:
- Publication type:
- Article
Bevacizumab in the Treatment of Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 4, p. 327
- By:
- Publication type:
- Article
Bevacizumab Slows Cancer Growth in Patients With Newly Diagnosed Advanced Breast Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 7, p. 810
- Publication type:
- Article
FDA Approves TCH Combination for HER2 -Positive Early Breast Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 7, p. 762
- Publication type:
- Article
Updated Study Results Reinforce Survival Benefit of Docetaxel for Men With Advanced, Hormone-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 9, p. 1143
- Publication type:
- Article
Hormone-Resistant Prostate Cancer: New Therapies Needed.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 2, p. 194
- By:
- Publication type:
- Article
Albumin Bound Pactlitaxel Improves Response Rate vs Docetaxel in Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 109
- Publication type:
- Article
Sifting Through the Multitude of Novel Therapies for Prostate Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1792
- By:
- Publication type:
- Article
Targeting Metastatic Prostate Cancer: The Search for Innovative Systemic Therapies.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1787
- By:
- Publication type:
- Article
Meta-Analysis Shows Benefits of Docetaxel in Patients With Advanced NSCLC.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 10, p. 1132
- Publication type:
- Article
Study of Tesmilifene Plus Docetaxel in Metastatic Breast Cancer Launched.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 11
- Publication type:
- Article
Advanced Non-Small-Cell Lung Cancer: New Data, Therapy Choices, and Challenging Decisions.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 6, p. 626
- By:
- Publication type:
- Article
Docetaxel Approved for Advanced Stomach Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 5, p. 525
- Publication type:
- Article
DocetaxellTrastuzumab Improves Disease-Free Survival in Early HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 5, p. 475
- Publication type:
- Article
Optimizing Adjuvant Chemotherapy in Early-Stage Breast Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 14, p. 1759
- By:
- Publication type:
- Article
Docetaxel Significantly Improves Survival Compared With Paclitaxel in Advanced Breast Cancer Patients.
- Published in:
- 2005
- Publication type:
- Report
The Cappuzzo/Finocchiaro/Trisolini el al Article Reviewed.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 8, p. 1003
- By:
- Publication type:
- Article
Perspectives on Salvage Therapy for Non-Small-Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 8, p. 989
- By:
- Publication type:
- Article
Study Shows Best Survival Rates Ever Reported for Patients With Locally Advanced Lung Cancer.
- Published in:
- 2005
- Publication type:
- Report
Earlier Docetaxel-Based Therapy Improves Survival, Reduces Recurrence in Breast Cancer.
- Published in:
- 2005
- Publication type:
- Report
Adding abiraterone to ADT and docetaxel improves rPFS: Approximate 2.5-year absolute benefit in median rPFS seen in men with de novo mCSPC.
- Published in:
- Urology Times, 2021, v. 49, n. 9, p. 20
- By:
- Publication type:
- Article
Sequential gemcitabine and docetaxel proves efficacious in NMIBC: Intravesical instillations prevent recurrence of non-muscle-invasive bladder cancer.
- Published in:
- Urology Times, 2020, v. 48, n. 8, p. 11
- By:
- Publication type:
- Article
Sequential gemcitabine and docetaxel proves efficacious in NMIBC.
- Published in:
- Urology Times, 2020, v. 48, n. 8, p. 1
- By:
- Publication type:
- Article
Sequential gemcitabine/docetaxel promising for recurrent NMIBC: Regimen could be alternative strategy for BCG-unresponsive patients.
- Published in:
- Urology Times, 2020, v. 48, n. 3, p. 38
- By:
- Publication type:
- Article
Race does not affect docetaxel/prednisone response: PSA/objective responses similar among cohorts, researchers report.
- Published in:
- Urology Times, 2019, v. 47, n. 7, p. 8
- By:
- Publication type:
- Article
Enzalutamide plus ADT improves rPFS in hormone-sensitive PCa.
- Published in:
- Urology Times, 2019, v. 47, n. 4, p. 4
- By:
- Publication type:
- Article
Sense of urgency surrounds BCG shortage.
- Published in:
- Urology Times, 2019, v. 47, n. 4, p. 1
- By:
- Publication type:
- Article
African-American patients fare well with chemo for prostate cancer.
- Published in:
- Urology Times, 2018, v. 46, n. 8, p. 7
- By:
- Publication type:
- Article
Chemo improves QoL in non-metastatic PCa.
- Published in:
- Urology Times, 2018, v. 46, n. 3, p. 6
- By:
- Publication type:
- Article
Two-drug therapy for urothelial Ca shows superior PFS.
- Published in:
- Urology Times, 2018, v. 46, n. 1, p. 8
- By:
- Publication type:
- Article
Upfront chemo for PCa? Yes, but...
- Published in:
- Urology Times, 2015, v. 43, n. 9, p. 3
- By:
- Publication type:
- Article
Data bolster upfront chemo's case in routine practice.
- Published in:
- Urology Times, 2015, v. 43, n. 9, p. 6
- By:
- Publication type:
- Article
Efficacy of new advanced PCa treatment affirmed.
- Published in:
- Urology Times, 2010, v. 38, n. 10, p. 6
- By:
- Publication type:
- Article
Advanced PCa agent prolongs progression-free survival.
- Published in:
- Urology Times, 2010, v. 38, n. 5, p. 10
- By:
- Publication type:
- Article
Monoclonal antibodies show antitumor efficacy in PCa.
- Published in:
- Urology Times, 2009, v. 37, n. 11, p. 27
- By:
- Publication type:
- Article
Neoadjuvant chemo combo no 'silver bullet' in prostate Ca.
- Published in:
- Urology Times, 2009, v. 37, n. 10, p. 24
- By:
- Publication type:
- Article
Novel PCa therapies focus on multiple targets.
- Published in:
- Urology Times, 2008, v. 36, n. 11, p. 22
- By:
- Publication type:
- Article
Combo Tx in high-risk Ca may reshape paradigm.
- Published in:
- Urology Times, 2007, v. 35, n. 10, p. 1
- By:
- Publication type:
- Article
Studies show promise for new, existing PCa drugs.
- Published in:
- Urology Times, 2007, v. 35, n. 2, p. 11
- By:
- Publication type:
- Article
Successive therapies may extend survival in AIPC.
- Published in:
- Urology Times, 2007, v. 35, n. 2, p. 9
- By:
- Publication type:
- Article
QoL improves with 21-day docetaxel regimen.
- Published in:
- Urology Times, 2006, v. 34, n. 11, p. 14
- By:
- Publication type:
- Article
Neoadjuvant chemo is well tolerated in high-risk PCa.
- Published in:
- Urology Times, 2006, v. 34, n. 11, p. 10
- By:
- Publication type:
- Article
Triple therapy may be option in hormone-refractory PCa.
- Published in:
- Urology Times, 2006, v. 34, n. 9, p. 28
- By:
- Publication type:
- Article
TAXOTERE: (docetaxel) Injection Concentrate.
- Published in:
- Urology Times, 2006, v. 34, n. 9, p. 16
- Publication type:
- Article